EyeGate Pharmaceuticals Completes $10 Million Public Stock Offering

By Staff
Monday, June 19, 2017 12:23 AM WALTHAM, Mass.—EyeGate Pharmaceuticals Inc., (NASDAQ:EYEG) a specialty pharmaceutical company focused on developing products for treating eye diseases and disorders, has completed its previously announced offering of common and preferred stock, according to an announcement last week.

EyeGate Pharmaceuticals Announces a $10 Million Public Offering

By Staff
Monday, June 12, 2017 12:23 AM WALTHAM, Mass.—EyeGate Pharmaceuticals Inc. (NASDAQ:EYEG), a specialty pharmaceutical company that focuses on developing and commercializing treatments for diseases and disorders of the eye, reported last week that it has set the pricing of a public stock offering that is expected to raise gross proceeds of $10 million.

CooperVision Revenues Rise Four Percent in Q2

By Staff
Friday, June 2, 2017 12:23 AM PLEASANTON, Calif.—The Cooper Companies, Inc. (NYSE:COO) announced financial results for the fiscal second quarter ended April 30, 2017.

TearClear Completes $4.5 Million Series A Financing and Introduces Leadership Team

By Staff
Wednesday, May 31, 2017 12:23 AM ORANGE COUNTY, Calif.—TearClear Corp., an early-stage, eye health technology company, reported Tuesday that it completed a Series A financing round that generated proceeds of $4.5 million.

NovaBay Pharmaceuticals Receives Noncompliance Notice from NYSE MKT

By Staff
Wednesday, May 24, 2017 12:25 AM EMERYVILLE, Calif.—NovaBay Pharmaceuticals (NYSE MKT: NBY) was notified last week by NYSE MKT, the New York Stock Exchange's market for small-cap companies, that it is not in compliance with the Exchange’s continued listing standards.

Aira Raises $12 Million Series B Financing

By Staff
Monday, May 22, 2017 12:23 AM SAN DIEGO—Aira, a San Diego-based startup that is developing smart products and services for blind and low vision individuals (BVI), announced that it has raised $12 million in a Series B funding round led by Jazz Venture Partners and Arboretum Ventures.

New Look Vision Group Reports Record Revenues as Company Adds 20 New Locations

By Staff
Friday, May 19, 2017 12:23 AM MONTREAL—New Look Vision Group Inc. (TSX:BCI) reported record revenues of $51 million and adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) of $7.9 million in its first quarter, representing increases of 14.5 percent and 8.3 percent, respectively, compared with the year-ago period.

Lensabl Secures New Funding to Support Growth and Plans to Offer Online Eye Exams

By Staff
Wednesday, May 17, 2017 12:26 AM LOS ANGELES—The start-up firm Lensabl, an online retailer of lenses, announced Tuesday that it has secured new funding.

Start-up Company Vivid Vision Raises $2 Million to Support its VR Treatment for Lazy Eye

By Staff
Wednesday, May 17, 2017 12:23 AM SAN FRANCISCO—The start-up Vivid Vision, which has developed a virtual reality (VR) tool to help treat binocular vision disorders, or lazy eye, has raised $2.2 million in a seed round of funding, the company announced last week.

Snap Inc., Marketer of Spectacles Sunglasses, Issues First Quarterly Financial Report

By Staff
Monday, May 15, 2017 12:23 AM VENICE, Calif.—Snap Inc. (NYSE: SNAP), which markets the video-enabled Spectacles sunglasses, last week issued its first quarterly financial report as a public company.

Zeiss Group Reports Growth ‘Across All Segments’ in First Half of Fiscal 2016-17

By Staff
Friday, May 12, 2017 12:26 AM OBERKOCHEN, Germany—The Zeiss Group reported Thursday that it “had a very successful end to the first six months” of its current fiscal year, with revenues rising 10 percent to €2.550 billion and earnings before interest and taxes (EBIT) increasing to €384 million, a total “significantly higher” than in the year-ago period.

Hoya Corp. Reports Increases in Sales and Pre-Tax Profit in Fourth Quarter

By Staff
Friday, May 12, 2017 12:23 AM TOKYO—Hoya Corp. (TOKYO:7741) Thursday reported that both fourth-quarter revenues and pre-tax profit increased.

Allergan Reports Solid Start to 2017 as Sales Rise 5 Percent to $3.6 Billion in First Quarter

By Staff
Wednesday, May 10, 2017 12:29 AM DUBLIN, Ireland—Allergan plc (NYSE: AGN) reported Tuesday that its first-quarter sales rose 5 percent to $3.6 billion compared with the year-ago quarter, and non-GAAP adjusted operating income from continuing operations totaled $1.6 billion, a decrease of 7 percent.

Valeant Reports First-Quarter Results and Raises Full-Year Adjusted Earnings Guidance Range

By Staff
Wednesday, May 10, 2017 12:26 AM LAVAL, Quebec—Valeant Pharmaceuticals International Inc. (NYSE: VRX) (TSX: VRX), parent company of Bausch + Lomb, reported Tuesday that divestiture efforts enabled the company to reduce its debt by $1.3 billion in the first quarter of 2017 and by $3.6 billion overall since the end of the first quarter of 2016.

Safilo Group Reports Sales Decline for Q1 2017

By Staff
Wednesday, May 10, 2017 12:23 AM PADUA, Italy—Safilo Group S.p.A.’s [SFL.IM] board of directors reviewed and approved Q1 2017 economic and financial key performance indicators.
Loading...